Rapamune 1 mg/ml, Lösung zum Einnehmen

7680552430024 CH-55243 Lösung
Rapamune 1 mg/ml, Lösung zum Einnehmen
Rapamune 1 mg/ml, Lösung zum Einnehmen
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
60
Selling units
60
Measure
ml
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/01/2026
Patient information leaflet
Français
30/01/2026
Patient information leaflet
Italien
30/01/2026
Summary of Product Characteristics
Allemand
30/01/2026
Summary of Product Characteristics
Français
30/01/2026
Summary of Product Characteristics
Italien
30/01/2026

Detailed composition

Substance Quantity Type Category
sirolimusum
1.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HNIDK
phosphatidylcholinum
- Substance HNIDK
sojae oleum
20.0 MG Substance HBESI
mono/diglycerida
- Substance HNIDK
ethanolum 96 per centum
20.0 MG Substance HBESI
propylenglycolum
350.0 MG Substance HBESI
E 304
- Substance HNIDK
ethanolum
3.17 PVV Substance HNIDK

Reimbursement information

Public price
CHF 279.80
Specialties list
Yes
Generic
No
SL addition date: 01/04/2001

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
55243
Drug name
Rapamune, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
L04AH01
Authorization status
Z
Dispensing category
B
First authorization
26/09/2000
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Package details

Description (FR)
RAPAMUNE sol 1 mg/ml fl 60 ml
Description (DE)
RAPAMUNE Lös 1 mg/ml Fl 60 ml
Market launch
26/09/2000
Narcotic (BTM)
No
Buy us a coffee Explore the data